Application Information

This drug has been submitted to the FDA under the reference 021971/001.

Names and composition

"LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE" is the commercial name of a drug composed of LAMIVUDINE and ZIDOVUDINE and NEVIRAPINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021971/001 LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE TABLET/ ORAL 150MG and 300MG and 200MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021939/001 Lamivudine, Zidovudine, Nevirapine Tabs 150mg/300mg/200mg LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE TABLET/ ORAL 150MG and 300MG and 200MG
021971/001 LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE TABLET/ ORAL 150MG and 300MG and 200MG
021988/001 Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE TABLET/ ORAL 150MG and 300MG and 200MG
022356/001 LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE TABLET/ ORAL 150MG and 300MG and 200MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved